These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16399366)
1. High-speed screening of human ATP-binding cassette transporter function and genetic polymorphisms: new strategies in pharmacogenomics. Ishikawa T; Sakurai A; Kanamori Y; Nagakura M; Hirano H; Takarada Y; Yamada K; Fukushima K; Kitajima M Methods Enzymol; 2005; 400():485-510. PubMed ID: 16399366 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design. Ishikawa T; Tamura A; Saito H; Wakabayashi K; Nakagawa H Naturwissenschaften; 2005 Oct; 92(10):451-63. PubMed ID: 16160819 [TBL] [Abstract][Full Text] [Related]
3. [Drug resistance mediated by ABC transporters]. Yoshikawa M; Ito A; Ishikawa T; Ikegami Y Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic importance of ABCG2. Cusatis G; Sparreboom A Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776 [TBL] [Abstract][Full Text] [Related]
5. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1). Ishikawa T; Sakurai A; Hirano H; Lezhava A; Sakurai M; Hayashizaki Y Pharmacol Ther; 2010 Apr; 126(1):69-81. PubMed ID: 20138191 [TBL] [Abstract][Full Text] [Related]
6. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics. Ishikawa T; Nakagawa H J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267 [TBL] [Abstract][Full Text] [Related]
7. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing]. Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Bruhn O; Cascorbi I Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314 [TBL] [Abstract][Full Text] [Related]
9. A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions. Saito H; Hirano H; Nakagawa H; Fukami T; Oosumi K; Murakami K; Kimura H; Kouchi T; Konomi M; Tao E; Tsujikawa N; Tarui S; Nagakura M; Osumi M; Ishikawa T J Pharmacol Exp Ther; 2006 Jun; 317(3):1114-24. PubMed ID: 16489126 [TBL] [Abstract][Full Text] [Related]
10. Human ABC transporter ABCG2 in cancer chemotherapy: drug molecular design to circumvent multidrug resistance. Ishikawa T; Saito H; Hirano H; Inoue Y; Ikegami Y Methods Mol Biol; 2012; 910():267-78. PubMed ID: 22821599 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Cascorbi I; Haenisch S Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Bosch TM Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231 [TBL] [Abstract][Full Text] [Related]
14. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Ieiri I; Higuchi S; Sugiyama Y Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037 [TBL] [Abstract][Full Text] [Related]
16. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy. Ishikawa T Adv Drug Deliv Rev; 2009 Jan; 61(1):1-2. PubMed ID: 19124052 [No Abstract] [Full Text] [Related]
18. ABCG2 -- a transporter for all seasons. Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903 [TBL] [Abstract][Full Text] [Related]
19. Methods to examine the impact of nonsynonymous SNPs on protein degradation and function of human ABC transporter. Ishikawa T; Wakabayashi-Nakao K; Nakagawa H Methods Mol Biol; 2013; 1015():225-50. PubMed ID: 23824860 [TBL] [Abstract][Full Text] [Related]
20. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Choudhuri S; Klaassen CD Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]